Clinical Study on Treating Acquired Blepharoptosis with Acupuncture and Injection to Some Acupoints
DOI:
https://doi.org/10.46966/msjar.v6i4.333Keywords:
Acupuncture, acquired blepharoptosis (ptosis), acupointAbstract
Background: In recent years, acquired blepharoptosis(ptosis) is seen on occasion and may result from high fever and viral infectious diseases. It may present with various symptoms, including visual field obstruction, headache, double vision, and fatigue. Therefore, more and more attention has been paid to early diagnosis and treatment of acquired ptosis. Objective: To observe the clinical effect of acupuncture and injection to some acupoints for acquired ptosis. Methods: 74 patients with acquired ptosis were randomly allocated into a study group with 42 cases (48 eyes) or a control one with 32 cases (39 eyes). The study group was treated with acupuncture and injection to some acupoints, while control group was treated with intramuscular injection of 0.05% proserine and administration of prednisolone. In study groups, 0.2mL of 0.05% proserine was injected to each pts of Chan Zhu (BL2), Yu Yao (EX-HN4), Tong Zi Liao (GB1) once in two days. In addition, in study groups, according to pattern identification, acupuncture was applied on the pts of Ge Shu (BL17), Qi Hai (CV6), San Yin Jiao(SP6) in qi-blood deficiency pattern, Zu San Li (ST36), San Yin Jiao(SP6), Pi Shu (BL20) in spleen qi weakness pattern, He Gu (LI4), Feng Chi (GB20), Tai Chong (LR3) in wind-phlegm pattern, He Gu (LI4), Tai Chong(LR3), Gan Shu (BL18) in qi-blood stagnation pattern. Results: The clinical efficacy was 91.6% in the study group, being significant as compared with the control one (79.6%; p< 0.05). Conclusions: Acupuncture and injection to some pts are effective for acquired ptosis and worthwhile to apply.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Yong Ran An, Myong Chan Chae, Kwang Hyok Kim, Il Choe, Mi Jang, Hyon Ju Jo, Jong Hui Kim, Sung Jin Kim
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
